Biodesix Inc

BDSX

Company Profile

  • Business description

    Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

  • Contact

    919 West Dillon Road
    LouisvilleCO80301
    USA

    T: +1 303 417-0500

    E: [email protected]

    https://www.biodesix.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    273

Stocks News & Analysis

stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.
stocks

Bluescope offer knocked back by board

Our view on the potential for additional offers.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,167.3040.200.44%
CAC 408,358.763.33-0.04%
DAX 4025,405.34143.700.57%
Dow JONES (US)49,590.2086.130.17%
FTSE 10010,140.7016.100.16%
HKSE26,846.35237.870.89%
NASDAQ23,733.9062.560.26%
Nikkei 22553,568.061,628.173.13%
NZX 50 Index13,640.8042.49-0.31%
S&P 5006,977.2710.990.16%
S&P/ASX 2008,837.7046.400.53%
SSE Composite Index4,163.841.44-0.03%

Market Movers